Canopy Growth Corporation (WEED.TO)
CAD 1.64
(0.61%)
CAD 1.64
(0.61%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 308.61 Million CAD | -57.15% |
| 2022 | 487.41 Million CAD | -6.32% |
| 2021 | 520.28 Million CAD | -21.94% |
| 2020 | 666.53 Million CAD | -32.89% |
| 2019 | 993.17 Million CAD | 54.56% |
| 2018 | 642.57 Million CAD | 319.8% |
| 2017 | 153.06 Million CAD | 236.94% |
| 2016 | 45.42 Million CAD | 123.74% |
| 2015 | 20.3 Million CAD | 149.08% |
| 2014 | 8.15 Million CAD | 774.94% |
| 2013 | 931.65 Thousand CAD | 1255.1% |
| 2012 | 68.75 Thousand CAD | 162.85% |
| 2011 | 26.15 Thousand CAD | -8.4% |
| 2010 | 28.55 Thousand CAD | 3.96% |
| 2009 | 27.46 Thousand CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 38.3 Million CAD | 5.42% |
| 2023 Q1 | 86.21 Million CAD | -20.96% |
| 2023 Q2 | 49.84 Million CAD | -42.19% |
| 2023 Q3 | 53.14 Million CAD | 6.64% |
| 2023 Q4 | 42.06 Million CAD | -20.86% |
| 2023 FY | 208.84 Million CAD | -57.15% |
| 2022 Q2 | 135.7 Million CAD | 24.66% |
| 2022 Q1 | 108.85 Million CAD | -15.79% |
| 2022 Q3 | 129.06 Million CAD | -4.89% |
| 2022 Q4 | 109.07 Million CAD | -15.49% |
| 2022 FY | 487.41 Million CAD | -6.32% |
| 2021 Q2 | 141.7 Million CAD | 18.17% |
| 2021 FY | 520.28 Million CAD | -21.94% |
| 2021 Q1 | 119.92 Million CAD | -28.27% |
| 2021 Q3 | 121.99 Million CAD | -13.91% |
| 2021 Q4 | 129.26 Million CAD | 5.96% |
| 2020 Q3 | 160.94 Million CAD | -4.9% |
| 2020 Q1 | 164.68 Million CAD | -40.71% |
| 2020 Q2 | 169.23 Million CAD | 2.77% |
| 2020 FY | 666.53 Million CAD | -32.89% |
| 2020 Q4 | 167.18 Million CAD | 3.88% |
| 2019 Q4 | 277.77 Million CAD | 21.57% |
| 2019 Q1 | 215.98 Million CAD | -5.75% |
| 2019 Q2 | 266.79 Million CAD | 23.52% |
| 2019 Q3 | 228.49 Million CAD | -14.36% |
| 2019 FY | 993.17 Million CAD | 54.56% |
| 2018 Q2 | 177.44 Million CAD | 150.6% |
| 2018 Q4 | 229.15 Million CAD | 38.74% |
| 2018 Q3 | 165.17 Million CAD | -6.91% |
| 2018 Q1 | 70.8 Million CAD | 23.59% |
| 2018 FY | 642.57 Million CAD | 319.8% |
| 2017 Q2 | 28.86 Million CAD | 24.95% |
| 2017 Q3 | 43.81 Million CAD | 51.8% |
| 2017 FY | 153.06 Million CAD | 236.94% |
| 2017 Q1 | 23.09 Million CAD | 28.18% |
| 2017 Q4 | 57.29 Million CAD | 30.77% |
| 2016 FY | 45.42 Million CAD | 123.74% |
| 2016 Q4 | 18.02 Million CAD | 66.75% |
| 2016 Q3 | 10.8 Million CAD | 16.35% |
| 2016 Q2 | 9.28 Million CAD | 27.02% |
| 2016 Q1 | 7.31 Million CAD | -1.31% |
| 2015 FY | 20.3 Million CAD | 149.08% |
| 2015 Q3 | 5.44 Million CAD | 25.2% |
| 2015 Q4 | 7.4 Million CAD | 36.12% |
| 2015 Q2 | 4.34 Million CAD | 40.16% |
| 2015 Q1 | 3.1 Million CAD | 2.84% |
| 2014 Q4 | 3.01 Million CAD | 4.55% |
| 2014 FY | 8.15 Million CAD | 774.94% |
| 2014 Q1 | 1.28 Million CAD | -14.03% |
| 2014 Q3 | 2.88 Million CAD | 15.73% |
| 2014 Q2 | 2.49 Million CAD | 94.43% |
| 2013 Q4 | 1.49 Million CAD | 5180.1% |
| 2013 FY | 931.65 Thousand CAD | 1255.1% |
| 2013 Q1 | 38.75 Thousand CAD | 558.78% |
| 2013 Q2 | 8266.00 CAD | -78.67% |
| 2013 Q3 | 28.24 Thousand CAD | 241.71% |
| 2012 Q3 | 12.92 Thousand CAD | -41.44% |
| 2012 FY | 68.75 Thousand CAD | 162.85% |
| 2012 Q2 | 22.07 Thousand CAD | 508.66% |
| 2012 Q4 | 5883.00 CAD | -54.49% |
| 2012 Q1 | 3627.00 CAD | -58.33% |
| 2011 Q3 | 10.16 Thousand CAD | 178.22% |
| 2011 Q1 | 1624.00 CAD | -81.45% |
| 2011 Q2 | 3655.00 CAD | 125.06% |
| 2011 Q4 | 8705.00 CAD | -14.4% |
| 2011 FY | 26.15 Thousand CAD | -8.4% |
| 2010 Q1 | 687.00 CAD | -92.17% |
| 2010 Q4 | 8755.00 CAD | -40.56% |
| 2010 FY | 28.55 Thousand CAD | 3.96% |
| 2010 Q3 | 14.72 Thousand CAD | 327.02% |
| 2010 Q2 | 3449.00 CAD | 402.04% |
| 2009 Q2 | - CAD | 0.0% |
| 2009 FY | 27.46 Thousand CAD | 0.0% |
| 2009 Q3 | 18 Thousand CAD | 0.0% |
| 2009 Q4 | 8777.00 CAD | -51.25% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Aurora Cannabis Inc. | 158.53 Million CAD | -94.659% |
| Avicanna Inc. | 14.59 Million CAD | -2014.969% |
| Avant Brands Inc. | 5.65 Million CAD | -5353.437% |
| Cardiol Therapeutics Inc. | 29.53 Million CAD | -944.82% |
| Crescita Therapeutics Inc. | 12.32 Million CAD | -2404.951% |
| Knight Therapeutics Inc. | 155.54 Million CAD | -98.409% |
| MediPharm Labs Corp. | 23.08 Million CAD | -1236.958% |
| OrganiGram Holdings Inc. | 277.81 Million CAD | -11.086% |
| Willow Biosciences Inc. | 7.55 Million CAD | -3985.385% |
| Auxly Cannabis Group Inc. | 40.28 Million CAD | -666.124% |